[Midazolam combined with neuroleptanesthesia as a hypnotic]

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• General anesthesia requires effective induction agents.
• Midazolam is a benzodiazepine with sedative and anesthetic properties.

Purpose of the Study:

• To evaluate the efficacy and safety of midazolam as an induction agent in general anesthesia.
• To compare the effects of two different midazolam doses (0.2 mg/kg vs. 0.4 mg/kg) on hemodynamic parameters.

Main Methods:

• A randomized study involving 40 women undergoing general anesthesia.
• Two groups received dextromoramide and droperidol, with one group receiving 0.2 mg/kg midazolam and the other 0.4 mg/kg midazolam.
• Hemodynamic parameters (blood pressure, heart rate) were monitored.

Main Results:

• Induction was satisfactory in over 90% of patients in both groups.
• Midazolam caused a statistically significant but physiologically unimportant decrease in blood pressure in both groups.
• Heart rate decreased significantly only in the higher midazolam dose group.
• Higher midazolam doses slightly reduced the required neuroleptic dose.

Conclusions:

• Midazolam is a suitable induction agent for neuroleptic-analgesic anesthesia.
• Doses exceeding 0.2 mg/kg provide limited additional benefit and are well-tolerated.
• The drug demonstrates a favorable safety profile during anesthetic induction and recovery.